G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $570,000 | +45.0% | 45,605 | -42.7% | 0.09% | +145.7% |
| Q2 2022 | $393,000 | -64.9% | 79,537 | +55.7% | 0.04% | -52.7% |
| Q2 2021 | $1,121,000 | -49.6% | 51,094 | -44.7% | 0.07% | -53.8% |
| Q1 2021 | $2,223,000 | +25.2% | 92,406 | -6.4% | 0.16% | +33.3% |
| Q4 2020 | $1,776,000 | +9.9% | 98,725 | -29.4% | 0.12% | +12.1% |
| Q3 2020 | $1,616,000 | +62.7% | 139,924 | +242.0% | 0.11% | +57.4% |
| Q2 2020 | $993,000 | – | 40,919 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |